Oxyvet

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oxyvet

Oxytetracycline

Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Oxyvet in the following countries:

• United States

International Drug Name Search

Viden

Viden may be available in the countries listed below.

Ingredient matches for Viden

Didanosine

Didanosine is reported as an ingredient of Viden in the following countries:

• Colombia

International Drug Name Search

Bicalutamid Ranbaxy

Bicalutamid Ranbaxy may be available in the countries listed below.

Ingredient matches for Bicalutamid Ranbaxy

Bicalutamide

Bicalutamide is reported as an ingredient of Bicalutamid Ranbaxy in the following countries:

• Austria

International Drug Name Search

Carprogesic

Carprogesic may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Carprogesic

Carprofen

Carprofen is reported as an ingredient of Carprogesic in the following countries:

• Germany


• Luxembourg

International Drug Name Search

Mi-Diabenil

Mi-Diabenil may be available in the countries listed below.

Ingredient matches for Mi-Diabenil

Glibenclamide

Glibenclamide is reported as an ingredient of Mi-Diabenil in the following countries:

• Tunisia

International Drug Name Search

Myderison

Myderison may be available in the countries listed below.

Ingredient matches for Myderison

Tolperisone

Tolperisone hydrochloride (a derivative of Tolperisone) is reported as an ingredient of Myderison in the following countries:

• Hungary

International Drug Name Search

Fucicream

Fucicream may be available in the countries listed below.

Ingredient matches for Fucicream

Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Fucicream in the following countries:

• Greece

Fusidic Acid

Fusidic Acid is reported as an ingredient of Fucicream in the following countries:

• Greece

International Drug Name Search

Meropen

Meropen may be available in the countries listed below.

Ingredient matches for Meropen

Meropenem

Meropenem is reported as an ingredient of Meropen in the following countries:

• Bangladesh

Meropenem trihydrate (a derivative of Meropenem) is reported as an ingredient of Meropen in the following countries:

• Japan

International Drug Name Search

Metozolv ODT

Metozolv ODT is a brand name of metoclopramide, approved by the FDA in the following formulation(s):

METOZOLV ODT (metoclopramide hydrochloride - tablet, orally disintegrating; oral)

• 
  Manufacturer: SALIX PHARMS
  
  Approval date: September 4, 2009
  
  Strength(s): EQ 10MG BASE ^[RLD], EQ 5MG BASE
  

Has a generic version of Metozolv ODT been approved?

No. There is currently no therapeutically equivalent version of Metozolv ODT available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Metozolv ODT. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Fast-Dispersing solid oral dosage form containing coarse particles
  Patent 6,413,549
  Issued: July 2, 2002
  Inventor(s): Richard; Green & Patrick; Kearney
  Assignee(s): R. P. Scherer Corporation
  This invention is directed to an oral solid, rapidly disintegrating, freeze-dried dosage form containing coarse particles of a pharmaceutically active material which are uncoated or coated with a polymer or lipid material. Preferably, the oral dosage form comprises coarse particles having a size in the range of 50 micron to 400 micron. The oral solid rapidly disintegrating dosage form according to the present invention preferably disintegrates in the oral cavity in less than 10 seconds.
  
  Patent expiration dates:
  
  
  • July 11, 2017
    
    ✓ 
    Drug product
  
  

See also...

• Metozolv ODT Consumer Information (Drugs.com)
• Metozolv ODT Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Metozolv ODT Consumer Information (Cerner Multum)
• Metozolv ODT Advanced Consumer Information (Micromedex)
• Metoclopramide Consumer Information (Drugs.com)
• Metoclopramide Consumer Information (Wolters Kluwer)
• Metoclopramide Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Metoclopramide Solution Consumer Information (Wolters Kluwer)
• Metoclopramide Syrup Consumer Information (Wolters Kluwer)
• Metoclopramide Consumer Information (Cerner Multum)
• Metoclopramide Advanced Consumer Information (Micromedex)
• Metoclopramide Intravenous Advanced Consumer Information (Micromedex)
• Metoclopramide Hydrochloride AHFS DI Monographs (ASHP)

Clopidogrel hydrochlorid Hexal

Clopidogrel hydrochlorid Hexal may be available in the countries listed below.

Ingredient matches for Clopidogrel hydrochlorid Hexal

Clopidogrel

Clopidogrel hydrochloride (a derivative of Clopidogrel) is reported as an ingredient of Clopidogrel hydrochlorid Hexal in the following countries:

• Germany

International Drug Name Search

Cefuroxima Ges

Cefuroxima Ges may be available in the countries listed below.

Ingredient matches for Cefuroxima Ges

Cefuroxime

Cefuroxime sodium salt (a derivative of Cefuroxime) is reported as an ingredient of Cefuroxima Ges in the following countries:

• Spain

International Drug Name Search